-
EP4223784
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4223784
| EP4223784 - COMPOSITIONS AND METHODS FOR MODULATING T-CELL MEDIATED IMMUNE RESPONSE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.05.2024 Database last updated on 28.03.2026 | |
| Former | Examination is in progress Status updated on 15.09.2023 | ||
| Former | Request for examination was made Status updated on 07.07.2023 | Most recent event Tooltip | 17.05.2024 | Application deemed to be withdrawn | published on 19.06.2024 [2024/25] | Applicant(s) | For all designated states The Regents of the University of Colorado, a body corporate 1800 Grant Street, 8th Floor Denver, CO 80203 / US | [2023/32] | Inventor(s) | 01 /
ZHU, Yuwen Parker, 80134 / US | 02 /
EDIL, Barish H. Castle Rock, 80108 / US | 03 /
SCHULICK, Richard D. Cherry Hills Village, 80113 / US | 04 /
PANICCIA, Alessandro Denver, 80209 / US | 05 /
KOENIG, Michelle Denver, 80203 / US | 06 /
SCHULICK, Alexander C. Denver, 80113 / US | [2023/32] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2023/32] | Application number, filing date | 23165603.4 | 02.09.2016 | [2023/32] | Priority number, date | US201562213305P | 02.09.2015 Original published format: US 201562213305 P | US201662370512P | 03.08.2016 Original published format: US 201662370512 P | [2023/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4223784 | Date: | 09.08.2023 | Language: | EN | [2023/32] | Type: | A3 Search report | No.: | EP4223784 | Date: | 04.10.2023 | Language: | EN | [2023/40] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.09.2023 | Classification | IPC: | C07K16/28, A61P35/00 | [2023/32] | CPC: |
A61K47/68 (EP,US);
C07K14/70503 (US);
A61K39/3955 (US);
A61K45/06 (US);
A61K47/6937 (EP,US);
A61P29/00 (EP);
A61P31/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
C07K14/7051 (US);
C07K14/70517 (US);
C07K14/70521 (US);
C07K16/28 (EP,US);
C07K16/2803 (US);
C07K2317/24 (EP,US);
C07K2317/31 (US);
C07K2317/34 (US);
C07K2317/51 (US);
C07K2317/515 (US);
C07K2317/565 (US);
C07K2317/622 (US);
C07K2317/76 (EP,US);
C07K2319/03 (US);
C07K2319/30 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/32] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION DER T-ZELL-VERMITTELTEN IMMUNANTWORT | [2023/32] | English: | COMPOSITIONS AND METHODS FOR MODULATING T-CELL MEDIATED IMMUNE RESPONSE | [2023/32] | French: | COMPOSITIONS ET PROCÉDÉS POUR MODULER UNE RÉPONSE IMMUNITAIRE À MÉDIATION PAR DES LYMPHOCYTES T | [2023/32] | Examination procedure | 30.03.2023 | Examination requested [2023/32] | 06.09.2023 | Date on which the examining division has become responsible | 18.09.2023 | Despatch of a communication from the examining division (Time limit: M04) | 30.01.2024 | Application deemed to be withdrawn, date of legal effect [2024/25] | 20.02.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/25] | Parent application(s) Tooltip | EP16771032.6 / EP3344657 | Fees paid | Renewal fee | 30.03.2023 | Renewal fee patent year 03 | 30.03.2023 | Renewal fee patent year 04 | 30.03.2023 | Renewal fee patent year 05 | 30.03.2023 | Renewal fee patent year 06 | 30.03.2023 | Renewal fee patent year 07 | 29.08.2023 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] WO2013184912 (ONCOMED PHARM INC et al.) | [XPI] WO2016134335 (COMPUGEN LTD et al.) | [XPI] WO2016134333 (COMPUGEN LTD et al.) | [IP] ZHU YUWEN ET AL: "Identification of CD112R as a novel checkpoint for human T cells", JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIV. PRESS, NEW YORK, NY, USA, vol. 213, no. 2, 8 February 2016 (2016-02-08), pages 167 - 176, XP009190107, ISSN: 1540-9538 | by applicant | US4675187 | US5475096 | US4946778 | US4816567 | US5545807 | US5545806 | US5569825 | US5625126 | US5633425 | US5661016 | WO9308829 | US4676980 | WO9100360 | WO9200373 | EP0003089 | US5530101 | US5859205 | US5585089 | US5693761 | US5693762 | US5777085 | US6180370 | US6210671 | US6329511 | WO8702671 | EP0173494 | EP0404097 | WO9311161 | WO9117271 | WO9201047 | WO9220791 | WO9312227 | WO9110741 | US6881557 | US6072035 | US5639641 | CARON ET AL., J. EXP MED., vol. 176, 1992, pages 1191 - 1195 | SHOPES, J. IMMUNOL., vol. 148, 1992, pages 2918 - 2922 | STEVENSON ET AL., ANTI-CANCER DRUG DESIGN, vol. 3, 1989, pages 219 - 230 | PETKOVA, S. B ET AL., INTL. IMMUNOL, vol. 18, 2006, pages 1759 - 1769 | DENG, R ET AL., MABS, vol. 4, 2012, pages 101 - 109 | OLAFSON, T, METHODS MOL. BIOL, vol. 907, 2012, pages 537 - 556 | LUND, J ET AL., MOL. IMMUNOL, vol. 29, 1992, pages 53 - 39 | LONBERG ET AL., NATURE, vol. 368, 1994, pages 812 - 859 | SAMBROOK ET AL., MOLECULAR CLONING: A LABORATORY MANUAL, 1989, pages 1 - 18 | MURAKAMI ET AL.: "The Molecular Basis of Cancer", 1995, WB SAUNDERS, article "Cell cycle regulation, oncogenes, and antineoplastic drugs" | IMMUN. REV, vol. 62, 1982, pages 185 | HOLLINGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5787 | MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 554 | KOZBOR ET AL., IMMUNOLOGY TODAY, vol. 4, 1983, pages 72 | KOHLERMILSTEIN, NATURE, vol. 256, 1975, pages 495 - 497 | COLE ET AL., MONOCLONAL ANTIBODIES AND CANCER THERAPY, 1985, pages 77 - 96 | MARKS ET AL., BIOTECHNOLOGY, vol. 10, 1992, pages 779 - 783 | JUNGHANS ET AL., CANCER RES., vol. 50, 1990, pages 1495 | AMON ET AL.: "Monoclonal Antibodies And Cancer Therapy", 1985, ALAN R. LISS, INC, article "Monoclonal Antibodies For Immunotargeting Of Drugs In Cancer Therapy", pages: 243 - 56 | COLIGAN, CURRENT PROTOCOLS IN IMMUNOLOGY, 1991 | HARLOWLANE, ANTIBODIES, A LABORATORY MANUAL, 1988 | SURESH ET AL., METHODS IN ENZYMOLOGY, vol. 121, 1986, pages 210 | KUBY, IMMUNOLOGY, 1997 | MARKS ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 779 - 783 | FISHWILD ET AL., NATURE BIOTECHNOLOGY, vol. 14, 1996, pages 826 - 51 | LONBERGHUSZAR, INTERN. REV. IMMUNOL, vol. 13, 1995, pages 65 - 93 | MARKS ET AL., BIOTECHNOLOGY, vol. 10, pages 779 - 783 | TRAUNECKER ET AL., EMBO J., vol. 10, 1991, pages 3655 - 3659 | JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525 | VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534 - 1536 | WINTER AND MILSTEIN, NATURE, vol. 349, 1991, pages 293 | MORRISON ET AL., PNAS USA, vol. 81, 1984, pages 6851 - 6855 | RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 327 | MORRISONOI, ADV. IMMUNOL., vol. 44, 1988, pages 65 - 92 | PRESTA, CURR. OP. STRUCT. BIOL, vol. 2, 1992, pages 593 - 596 | PADLAN, MOLEC. IMMUN., vol. 28, 1991, pages 489 - 498 | PADLAN, MOLEC. IMMUN., vol. 31, no. 3, 1994, pages 169 - 217 | CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917 | THORPE ET AL.: "Monoclonal Antibodies `84: Biological And Clinical Applications", 1985, article "Antibody Carriers Of Cytotoxic Agents In Cancer Therapy: A Review", pages: 475 - 506 | THORPE ET AL.: "Immunol. Re<<.", vol. 62, 1982, article "The Preparation And Cytotoxic Properties Of Antibody-Toxin Conjugates", pages: 119 - 58 | ZAPATA ET AL., PROTEIN ENG, vol. 8, no. 10, 1995, pages 1057 - 1062 | BARBAS ET AL., PROC NAT. ACAD. SCI. USA, vol. 113, 1994, pages 3809 - 3813 | XU ET AL., IMMUNITY, vol. 13, 2000, pages 37 - 45 | PULE, MFINNEY HLAWSON A: "Artificial T-cell receptors", CYTOTHERAPY, vol. 248, no. 3, 2003, pages 211 - 26, XP008028247, DOI: 10.1080/14653240310001488 | HAMERS-CASTERMAN ET AL., NATURE, vol. 363, 1993, pages 446 - 448 | SHERIFF ET AL., NATURE STRUCT. BIOL, vol. 3, 1996, pages 733 - 736 | KABAT ET AL.: "Sequences of Proteins of Immunological Interest", 1991, DEPARTMENT OF HEALTH AND HUMAN SERVICES | SCHIER ET AL., GEN EL, vol. 69, 1995, pages 147 - 155 | JACKSON ET AL., J. IMMUNOL., vol. 154, no. 7, 1995, pages 3310 - 2004 | HAWKINS ET AL., J. MOL. BIOL., vol. 226, 1992, pages 889 - 896 | SMITHWATERMAN, ADV. APPL. MATH, vol. 2, 1970, pages 482 | NEEDLEMANWUNSCH, J. MOL. BIOL, vol. 48, 1970, pages 443 | PEARSONLIPMAN, PROC. NAT'L. ACAD. SCI. USA, vol. 85, 1988, pages 2444 | ALTSCHUL ET AL., NUC. ACIDS RES, vol. 25, 1977, pages 3389 - 3402 | ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410 | HENIKOFFHENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1989, pages 10915 | ROGUSKA ET AL., PROTEIN ENG, vol. 9, 1996, pages 895 | "Remington's Pharmaceutical Science", 1980, MACK PUBLISHING COMPANY | PASCALIS ET AL., J. IMMUNOL., vol. 169, 2002, pages 1119 | VAJDOS ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 320, 2002, pages 415 - 428 | IWAHASHI ET AL., MOL. IMMUNOL, vol. 36, 1999, pages 1079 - 1091 | TAMURA ET AL., JOURNAL OF IMMUNOLOGY, vol. 164, 2000, pages 1432 - 1441 | GONZALES ET AL., MOL. IMMUNOL, vol. 41, 2004, pages 863 | WINTER, FEES LETT, vol. 23, 1998, pages 92 | STUDNICAK ET AL., PROTEIN ENG, vol. 7, 1994, pages 805 | VASWAMI ET AL., ANNALS OF ALLERGY, ASTHMA AND IMMUNOLOGY, vol. 81, 1998, pages 105 | BIRD, R. E.HARDMAN, K. D.JACOBSON, J. W.JOHNSON, S.KAUFMAN, B. M.LEE, S.M.LEE, T.POPE, S. H.RIORDAN, G. SWHITLOW, M, METHODS OF MAKING SCFV ANTIBODIES HAVE BEEN DESCRIBED, 1988 | HUSE ET AL., SCIENCE, vol. 246, 1989, pages 1275 - 1281 | WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546 | VAUGHAN ET AL., NATURE BIOTECH, vol. 14, 1996, pages 309 - 314 |